Related Experiment Video
Updated: May 24, 2025

12:04
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
28.8K
Basic science and translational implications of current knowledge on neuroendocrine tumors
Lynnette Fernandez-Cuesta1, Nicolas Alcala1, Emilie Mathian1
1Computational Cancer Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
The Journal of Clinical Investigation
|March 3, 2025
Summary
Neuroendocrine tumors (NETs) are increasingly diagnosed, necessitating updated classifications. Understanding NET biology, tumor microenvironment, and cells of origin is crucial for personalized therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Neuroendocrine tumors (NETs) are a diverse malignancy group with increasing incidence.
- NETs commonly affect the lungs and gastrointestinal tract.
- Current classification systems require updates to reflect advances in NET biology.
Purpose of the Study:
- To review recent progress in understanding NET biology, focusing on the tumor microenvironment and cells of origin.
- To highlight the need for evolving classification systems incorporating molecular subtypes.
- To emphasize the development of morphomolecular classification for personalized therapies.
Main Methods:
- Review of omics studies revealing molecular subtypes of NETs.
- Analysis of tumor microenvironment and cell of origin data.
- Examination of immune infiltration profiles in NETs.
Main Results:
- Molecular subtypes of NETs have been identified through omics studies.
- Diverse cells of origin and tumor microenvironments contribute to NET heterogeneity.
- Low immune infiltration may correlate with aggressive NET cases and metastasis.
Conclusions:
- NETs exhibit significant molecular and microenvironmental heterogeneity.
- A morphomolecular classification system is urgently needed for NETs.
- This approach will improve characterization, identify therapeutic targets, and guide personalized treatments.

